Genital Dysplasia and Immunosuppression: Why Organ-Specific Therapy Is Important | Zendy

Raphael Sager | Zendy; Pascal Frei | Zendy; Urs C. Steiner | Zendy; Daniel Fink | Zendy; Cornelia Betschart | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Genital Dysplasia and Immunosuppression: Why Organ-Specific Therapy Is Important

Author(s) -

Raphael Sager,

Pascal Frei,

Urs C. Steiner,

Daniel Fink,

Cornelia Betschart

Publication year - 2019

Publication title -

inflammatory intestinal diseases

Language(s) - English

Resource type - Journals

eISSN - 2296-9403

pISSN - 2296-9365

DOI - 10.1159/000502687

Subject(s) - medicine , immunosuppression , dysplasia , colposcopy , cervical intraepithelial neoplasia , vedolizumab , hpv infection , sex organ , intraepithelial neoplasia , gastroenterology , biopsy , dermatology , gynecology , ulcerative colitis , cervical cancer , disease , cancer , prostate , biology , genetics

Young patients with Crohn's disease (CD) show a high prevalence of human papillomavirus (HPV) which is the main cause of high-grade squamous intraepithelial lesions (HSIL). A major complication for patients undergoing immunocompromising therapy is the development of genital dysplasia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research